Pharsight, the maker of Phoenix® WinNonlin®, provides best-in-class PK/PD analysis, biostatistics and regulatory reporting services that are the backbone of every regulatory submission package. Equipped with Pharsight's own leading software and data management tools, we are your global partner for on-time, on-budget, on-target study analysis and reporting from preclinical through Phase IV.
Pharsight | 321 East Evelyn Avenue, 3rd Floor
Mountain View, CA 94041-1530
Tel: 650.314.3800 | Fax: 650.314.3810
|
|
|
Website:
Pharsight Team Profile, Experience and Approach available at: Pharsight Online
Data Sheet:
Benefits of Combining PK/PD Expertise and Technology for New Drug Approval
Download Capabilities Summary
Upcoming Event:
Turning PK/PD Data into Knowledge in Non-Clinical and Clinical Studies
Featured Speaker: Jean-Francois Marier, PhD., FCP, Lead Scientist, Pharsight
Register to Attend May 11 Oncology Biomarker Symposium - Montreal, Quebec |
